News - NX Development Corp

NX Development Corp. Names Salvatore DeSena, M.D., as Chief Executive Officer

LEXINGTON, KY |GlobeNewswire| March 02, 2022 — NX Development Corp. (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced that...

2021 CNS Annual Meeting

Lexington, KY | October 25, 2021—NX Development Corp. exhibited at the 2021 Congress of Neurological Surgeons (CNS) Annual Meeting in Austin, TX. This meeting could be...

NX Development Corp. (NXDC) Receives FDA Orphan-Drug Designation for Gleolan® (aminolevulinic acid HCl) in Meningioma

Lexington, KY, Jan. 12, 2021 (GLOBE NEWSWIRE) — NX Development Corp. (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced FDA...

NX DEVELOPMENT CORP. (NXDC) LAUNCHES GLEOLAN™ (AMINOLEVULINIC ACID HCL) MENINGIOMA PHASE III CLINICAL TRIAL (NXDC-MEN-301)

LEXINGTON, KY |GlobeNewswire| November 17, 2020 — NX Development Corp (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced the...

Lexington-Based NX Development Corp (NXDC) Announces Baptist Health Lexington is First Hospital in Kentucky to Use Breakthrough Imaging Agent for Brain Tumor Visualization

Dr. Christian Ramsey first neurosurgeon in state to use Gleolan™ for enhanced visualization of high-grade gliomas/glioblastoma

AANS 2019

Lexington, KY | September 1, 2019 — NXDC was proud to be an exhibitor and supporter of the American Association of Neurological Surgeons Annual Scientific Meeting...

NX Development Corp. (NXDC) Launches FDA-Approved Gleolan™ (aminolevulinic acid HCl) for Enhanced Visualization of High-Grade Gliomas (including Glioblastomas)

Lexington, Kentucky | October, 2018 — NX Development Corp. (NXDC), a life sciences company, today announced the U.S. commercial launch of its flagship product Gleolan™...

NX Development Corp (NXDC) Announces Merger Acquisition by photonamic GmbH & Co. KG, a German Biotech Firm Engaged in 5-ALA-Related Pharmaceutical Business in Europe

LEXINGTON, KY | April 30, 2018 /PRNewswire/ — NX Development Corp (NXDC), a privately-held life sciences company, today announced a Merger Acquisition as a result of...